Nu Skin Enterprises, Inc. (NUS)
NYSE • Consumer Defensive
Last close at October 5, 2026 at 20:00 UTC
Metrics Over Time
Where the Money Goes
Q2 2026In plain terms: out of every $100 in revenue, Nu Skin Enterprises, Inc. currently loses $78.
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
Nov 5
in 30 daysQ4 2026% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
Nu Skin Enterprises said, based on preliminary results for the second fiscal quarter of 2026 reported on August 10, that adjusted EPS of $0.20 matched the $0.20 consensus, while revenue of about $320.1 million missed the $345.2 million estimate by 7.3%. Revenue fell roughly 17% from about $386.1 million a year ago, and gross profit came in at about $218.3 million with gross margin near 68%, keeping profitability tied to a lower top line. Operating cash flow was $10.6 million, and the company paid $2.9 million in dividends.
Next report — what to expect
Nu Skin Enterprises, Inc. (NUS) reports earnings on November 5, 2026. Wall Street expects EPS of $0.21 on revenue of $328.7 million. For trailing context, revenue declined -17.1% year over year last quarter. Nu Skin has beaten EPS in 4 of its 8 most recent quarters.
About Nu Skin Enterprises, Inc.
Nu Skin Enterprises, Inc. (NYSE: NUS) sells beauty, personal care, and nutritional products in the consumer household and personal care market, with $1.5 billion in FY2025 revenue. Its portfolio centers on the ageLOC and Pharmanex brands and spans skincare systems, cleansing devices, supplements, and weight-management offerings sold across international markets.
Today's Snapshot
NUS closed slightly higher at 4.63.
Trading Volume
Below 10d avg (461.6K)
458.9K
vs S&P 500 Today
Moderate Underperformance
-0.23%
Updated: October 6, 2026 at 12:15 UTC
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$4.62 - $6.90Sell
- RSI (14)46.11Neutral
- Stochastic %K (14, 3, 3)33.45Neutral
- MACD Level (12, 26)-0.07Neutral
Peers & Related Assets
Get premium market insights delivered directly to your inbox.